Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Oct 26, 2020

Keywords

ClinConnect Summary

This clinical trial is investigating the use of virtual reality (VR) as a new way to help people quit smoking. Tobacco addiction can lead to serious health problems, and while many people want to quit, traditional treatments don’t always work well. The researchers aim to create a VR program that helps smokers deal with situations that might tempt them to relapse, or start smoking again. They will measure how this program affects the time it takes for participants to relapse and their desire to smoke.

To be eligible for this trial, participants need to be between 18 and 75 years old, smoke at least 10 cigarettes a day, and want to quit smoking. They should be able to read and speak French and be covered by the French national health insurance. However, individuals with certain mental health issues, severe health conditions, or who are part of vulnerable populations, like pregnant women or those unable to give consent, cannot participate. Those who join the study can expect to engage with the VR treatment and share their experiences, which will help researchers understand if this new approach is effective in supporting smoking cessation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female between 18 and 75 years of age
• • Who smokes 10 or more cigarettes per day in the month prior to inclusion
• • Who wants to quit smoking
• • Who has a diagnosis of a smoking disorder with "craving" criteria according to DSM 5 criteria
• • Who is able to speak and read French
• • Who is covered by the French national health insurance system
• • Who has a signed consent form
• Exclusion Criteria:
• • Subjects with decompensated psychiatric co-morbidities (DSM 5) or unstable organic disease
• • Subjects at serious suicide risk
• • Subjects with other substance use disorders (DSM 5)
• • Problems that interact with 3D exposure: tendency to dissociation; interceptive phobias (panic attacks and hypochondria...); severe dizziness.
• • Cognitive problems that limit or prevent the ability to implement coping strategies or the management of emotions or stimuli and disabilities to complete the questionnaires
• • Subjects belonging to a protected population such as pregnant women, breastfeeding women, guardians
• • Subjects deprived of liberty by judicial or administrative decision, subject to psychiatric treatment under duress, minor subject, or unable to express their consent
• • Who refuses to participate